Royal Bank of Canada’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
403,916
+16,885
| +4% | +$57.9K | ﹤0.01% | 3320 |
|
|
2025
Q1 | $863K | Sell |
387,031
-19,960
| -5% | -$44.5K | ﹤0.01% | 3276 |
|
|
2024
Q4 | $1.19M | Sell |
406,991
-393
| -0.1% | -$1.15K | ﹤0.01% | 3003 |
|
|
2024
Q3 | $1.06M | Sell |
407,384
-1,490
| -0.4% | -$3.87K | ﹤0.01% | 3121 |
|
|
2024
Q2 | $1.21M | Buy |
408,874
+16,517
| +4% | +$48.9K | ﹤0.01% | 2966 |
|
|
2024
Q1 | $1.78M | Buy |
392,357
+4,238
| +1% | +$19.2K | ﹤0.01% | 2679 |
|
|
2023
Q4 | $2.22M | Sell |
388,119
-6,483
| -2% | -$37K | ﹤0.01% | 2558 |
|
|
2023
Q3 | $1.82M | Sell |
394,602
-93,243
| -19% | -$429K | ﹤0.01% | 2540 |
|
|
2023
Q2 | $3.15M | Sell |
487,845
-663,416
| -58% | -$4.29M | ﹤0.01% | 2158 |
|
|
2023
Q1 | $8.68M | Buy |
1,151,261
+36,747
| +3% | +$277K | ﹤0.01% | 1464 |
|
|
2022
Q4 | $11.3M | Buy |
1,114,514
+26,041
| +2% | +$264K | ﹤0.01% | 1326 |
|
|
2022
Q3 | $10.8M | Buy |
1,088,473
+330,870
| +44% | +$3.27M | ﹤0.01% | 1289 |
|
|
2022
Q2 | $8.07M | Sell |
757,603
-69,690
| -8% | -$742K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $8.07M | Sell |
827,293
-17,069
| -2% | -$166K | ﹤0.01% | 1635 |
|
|
2021
Q4 | $12.1M | Buy |
844,362
+657,862
| +353% | +$9.41M | ﹤0.01% | 1503 |
|
|
2021
Q3 | $3.74M | Buy |
186,500
+32,923
| +21% | +$660K | ﹤0.01% | 2210 |
|
|
2021
Q2 | $3.38M | Buy |
153,577
+86,785
| +130% | +$1.91M | ﹤0.01% | 2296 |
|
|
2021
Q1 | $2.27M | Buy |
66,792
+63,721
| +2,075% | +$2.16M | ﹤0.01% | 2539 |
|
|
2020
Q4 | $123K | Buy |
+3,071
| New | +$123K | ﹤0.01% | 4668 |
|